Biotech Values

[genisi]

It was striking that the two mutations that emerged in practice and were disclosed in the NEJM article were among those listed as possible by Ariad.

I don't know if it should be really striking as predicting patterns of mutations arising during drug therapy using in vitro mutagenesis screen in cells, isn't a new method and has been used before for other drugs.